Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

Conditions

• Soft Tissue Sarcoma
• Neoplasms, Connective and Soft Tissue
• Sarcoma Metastatic
• Sarcoma,Soft Tissue

Interventions

• DRUG: Camrelizumab
• DRUG: Adriamycin

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology